INCIDENCE OF SEVERE SEPSIS IN THE NETHERLANDS- A POINT PREVALENCE SURVEY

Author(s)

Van Gestel A1, Bakker J2, Veraart C3, Van Hout B1, 1PharMerit BV, Capelle ad Yssel, Netherlands; 2Isala Klinieken, Zwolle, Netherlands; 3Eli Lilly Nederland BV, Houten, Netherlands

OBJECTIVES: To determine the annual incidence of severe sepsis in the Netherlands by performing a point-prevalence survey in multiple intensive care units. METHODS: ICU's were invited to participate in a one-day survey and monitor patients during the first 24 hours of their stay, if they were admitted with a proven/suspected infection. Patient-specific questionnaires captured demographic and clinical information, presence of Systemic Inflammatory Response Syndrome (SIRS), and the functional status of seven organ systems. The annual national incidence was calculated from the results of the survey following two approaches: 1) by multiplying the survey incidence (patients/day) with the number of days per year, corrected for the fact that the survey was held on a weekday, and 2) by using the relation P=I·D (P for prevalence, I for incidence and D for duration of stay) in which P was known from the survey and D was estimated as the geometrical mean of duration-to-date. RESULTS: Forty-seven ICU's participated (in 43 general and 4 university hospitals), representing 42% of the national admission capacity. During the study-period, 18 patients meeting criteria for severe sepsis were newly admitted, and another 116 patients with severe sepsis were already present. According to the first calculation method, the annual incidence of severe sepsis was 13,137 ± 2,821 patients, whereas the second method, with an estimated D of 13.3 ± 1.1 days, lead to a calculated incidence of 8,643 ± 929 patients/year. CONCLUSIONS: Using the results from a point-prevalence survey, different approaches lead to different outcomes. Both approaches hold advantages and disadvantages. The second method is considered superior because it is based on a larger population and is less sensitive to daily variations.

Conference/Value in Health Info

2002-11, ISPOR Europe 2002, Rotterdam, The Netherlands

Value in Health, Vol. 5, No. 6 (November/December 2002)

Code

PIN36

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×